Mirum Pharmaceuticals Inc
MIRM
Market Cap$2.2B
Close$
$27.50
38.4% downside
Current Fair Value
38.4% downsideOvervalued by 38.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.20 Billion |
|---|---|
| Enterprise Value | $2.31 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.85 |
| Beta | 0.96 |
| Outstanding Shares | 48,889,058 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -28.1 |
|---|---|
| PEG | 67.01 |
| Price to Sales | 6.38 |
| Price to Book Ratio | 11.16 |
| Enterprise Value to Revenue | 6.08 |
| Enterprise Value to EBIT | -34.06 |
| Enterprise Value to Net Income | -30 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 1.36 |
Revenue Sources
No data
Insider Trades
ESG Score
No data